The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

被引:61
|
作者
Mooradian, AD
Haas, MJ
Wong, NCW
机构
[1] St Louis Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet & Metab, St Louis, MO 63104 USA
[2] Univ Calgary, Dept Med & Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada
关键词
D O I
10.1210/er.2005-0013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
One of the factors contributing to the increased risk of developing premature atherosclerosis is low plasma concentrations of high-density lipoprotein (HDL) cholesterol (HDLc). Multiple potential mechanisms account for the cardioprotective effects of HDL and its main protein apolipoprotein A-I (apo A-I). The low plasma concentrations of HDL could be the result of increased fractional clearance and reduced expression of apo A-I. To this end, nutrients play an important role in modulating the fractional clearance rate, as well as the rate of apo A-I gene expression. Because medical nutrition therapy constitutes the cornerstone of management of dyslipidemias, it is essential to understand the mechanisms underlying the changes in HDL level in response to alterations in dietary intake. In this review, we will discuss the effect of select nutrients on serum HDLc and apo A-I levels. Specifically, we will review the literature on the effect of carbohydrates, fatty acids, and ketones, as well as some of the nutrient-related metabolites, such as glucosamine and the prostanoids, on apo A-I gene expression. Because there are multiple mechanisms involved in the regulation of serum HDLc levels, changes in gene transcription do not necessarily correlate with clinical observations on serum levels of HDLc.
引用
收藏
页码:2 / 16
页数:15
相关论文
共 50 条
  • [21] Nevirapine Increases High-Density Lipoprotein Cholesterol Concentration by Stimulation of Apolipoprotein A-I Production
    Franssen, Remco
    Sankatsing, Raaj R.
    Hassink, Elly
    Hutten, Barbara
    Ackermans, Mariette T.
    Brinkman, Kees
    Oesterholt, Rene
    Arenas-Pinto, Alejandro
    Storfer, Stephen P.
    Kastelein, John J.
    Sauerwein, Hans P.
    Reiss, Peter
    Stroes, Erik S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (09) : 1336 - 1341
  • [22] Low high-density lipoprotein cholesterol and apolipoprotein A-I levels are associated with poor outcome and relapse in autoimmune encephalitis
    Liu, Fei
    Huang, Teng
    Wang, Baojie
    Wang, Chunjuan
    Guo, Shougang
    NEUROSCIENCE LETTERS, 2022, 775
  • [23] MINIMAL WITHIN-DAY VARIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN A-I LEVELS IN NORMAL SUBJECTS
    HENDERSON, LO
    SARITELLI, AL
    LAGARDE, E
    HERBERT, PN
    SHULMAN, RS
    JOURNAL OF LIPID RESEARCH, 1980, 21 (07) : 953 - 955
  • [24] INVITRO MODULATION OF THE APOLIPOPROTEIN COMPOSITION OF HIGH-DENSITY LIPOPROTEIN - DISPLACEMENT OF APOLIPOPROTEIN A-I FROM HIGH-DENSITY LIPOPROTEIN BY APOLIPOPROTEIN-A-II
    LAGOCKI, PA
    SCANU, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (08) : 3701 - 3706
  • [25] High-Density Lipoprotein Cholesterol Efflux, Nitration of Apolipoprotein A-I, and Endothelial Function in Obese Women
    Vazquez, Edward
    Sethi, Amar A.
    Freeman, Lita
    Zalos, Gloria
    Chaudhry, Hira
    Haser, Erin
    Aicher, Brittany O.
    Aponte, Angel
    Gucek, Marjan
    Kato, Gregory J.
    Waclawiw, Myron A.
    Remaley, Alan T.
    Cannon, Richard O., III
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (04): : 527 - 532
  • [26] Early prediction of persistent organ failure by serum apolipoprotein A-I and high-density lipoprotein cholesterol in patients with acute pancreatitis
    Zhoua, Chen-Liang
    Zhang, Chi-Hao
    Zhao, Xiang-Yun
    Chen, Shu-Huai
    Liang, Hui-Jie
    Hu, Chun-Liang
    Chen, Ni-Wei
    CLINICA CHIMICA ACTA, 2018, 476 : 139 - 145
  • [27] REDUCTION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND APOLIPOPROTEIN A-I CONCENTRATIONS BY A LIPID-LOWERING DIET
    VESSBY, B
    BOBERG, J
    GUSTAFSSON, IB
    KARLSTROM, B
    LITHELL, H
    OSTLUNDLINDQVIST, AM
    ATHEROSCLEROSIS, 1980, 35 (01) : 21 - 27
  • [28] Anti-Inflammatory Functions of Apolipoprotein A-I and High-Density Lipoprotein Are Preserved in Trimeric Apolipoprotein A-I
    Murphy, Andrew J.
    Anh Hoang
    Aprico, Andrea
    Sviridov, Dmitri
    Chin-Dusting, Jaye
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 344 (01): : 41 - 49
  • [29] Relationship between non-high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
    Li, Ya
    Li, Shu
    Ma, Yulin
    Li, Jialing
    Lin, Mingying
    Wan, Jing
    CORONARY ARTERY DISEASE, 2020, 31 (07) : 623 - 627
  • [30] Apolipoprotein A-I Structure in Native Mouse High-Density Lipoprotein and Impact of Serum Amyloid A Presence
    Huang, Rong
    de Beer, Marcielle
    de Beer, Frederick
    Davidson, W.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E289 - E289